Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2012-05-02

Clinical Trial Update: Assessment of HBV Vaccine Immunity After 18 Years

View source ↗

Summary

A clinical trial update assessing immunity to Hepatitis B vaccine 18 years after vaccination.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: Medical Corps, Israel Defense Force | Conditions: Hepatitis b Vaccine | Status: UNKNOWN